Navigation Links
OPPI Opposes Draft National Pharmaceuticals Policy

Coming down heavily on the draft National Pharmaceuticals Policy, industry body OPPI has said the proposed policy will hamper the growth of the pharmaceutical sector // and lead to the destruction of Indian pharma companies.

"The previous governments had reduced the number of drugs under control from 347 to 143 and finally to 74. The Drug Policy in February 2002 had proposed a further reduction from 74 to about 30. The current policy hence will not promote the industry but would hamper its growth," Director General of Organisation of Pharmaceutical Producers of India Ajit V Dangi told PTI.

"The move (of bringing more drugs under price control) will act as a barrier to our growing markets and it will lead to the destruction of Indian Pharma companies," he said.

Instead of widening the list of drugs under the price control regime, the government should ensure access to basic healthcare facilities, Dangi added.

Criticising the proposal to include 354 drugs in the price control regime, he said it would drastically hit the margins of drug manufacturers.

He said the prices of medicines were already lowest in India, even lower than other neighbouring countries like Bangladesh, Sri lanka and Indonesia and there were no apparent reasons to reduce them further.

If the government wanted to lower it further then it should be looking at drugs taxation, he observed. The easier way to reduce prices is to cut taxes such as excise duty which push the prices of medicines up by 75 percent.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. HIV Patients Opposes Patenting Of AIDS Drug
2. Goa Christian Council Opposes Mandatory HIV Test
3. Smoking Ban Draft Is Put For Consultation
4. Kerala Drafts a New Health Tourism Policy
5. National Lung Study in the process
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Hepatitis B Vaccine To Be Included In National Immunization Programme
8. UK Govt Says On Course For National Chlamydia Screening
9. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
10. India extends National TB Control Program
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
Breaking Medicine Technology: